About
Pure-DEL develops self-purified DNA-encoded libraries of complex synthetic macrocycles to facilitate drug discovery targeting challenging and traditionally undruggable pharmaceutical targets.
Explore Pure-DEL's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.